Body weight management research hub

A Phase 1 Trial Assessing Pharmacokinetics and Safety of CAM2056 (Semaglutide Subcutaneous Depot)

This study is looking at a new way to give a well-known medicine called semaglutide. It's for managing body weight. In this first study in humans, doctors want to see how the new medicine works in the body and if it's safe. It's open to adults aged 18 and over.